Global Dilated Cardiomyopathy Therapeutics Market to Reach $485.3 Million by 2030
The global market for Dilated Cardiomyopathy Therapeutics estimated at US$361.9 Million in the year 2023, is expected to reach US$485.3 Million by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. Angiotensin II Receptor Blockers (ARBs) Drug Class, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$234.2 Million by the end of the analysis period. Growth in the Beta-Blockers Drug Class segment is estimated at 4.2% CAGR for the next 7-year period.
The U.S. Market is Estimated at $107.8 Million, While China is Forecast to Grow at 4% CAGR
The Dilated Cardiomyopathy Therapeutics market in the U.S. is estimated at US$107.8 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$85.2 Million by the year 2030 trailing a CAGR of 4% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.2% and 3.4% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook